1Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia [ J ]. Blood, 2000,95 ( 1 ) :309-313.
2Zachary I. Molecules in focus vascular endothelial growth factor [ J ].IJBCB, 1998,30( 11 ) : 1169-1174.
3Ferrara N. Molecular and biological properties of vascular endothelial growth factor[J] .J Mol Med, 1999,77(7):527-543.
4Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors[J] .J FASEB, 1999,13(1) :9-22.
5Robinson C J, Stringer SE. The splice variants of vascular endothelial growth factor(VEGF) and their receptors[J] .J Cell Science, 114(5) :853-865.
6Keyhani A, Jendiroba DB, Freireich EJ. Angiogencsis and leukemia[J]. Leukemia Res,2001,25(8) :639-645.
7Shibuya M. Structure and dual function of vascular endothelial growth factor receptor-1 ( Fh-1 ) [ J]. UBCB,2001,33(4) :409-420.
8Mangi MH. Angiogenesis and angiogenic mediators in haematological malignancies [J]. Br J Haematol,2000,111 ( 1 ) :43-51.
9Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and AI in vascular endothelial cells [J] .J Biol Chem,1998,273(21) :13313-13316.
10Majka M ,Janowska-Wieczorek A, Ratajczak J, et al. Numerous growth factors,cytokines,and chemokines are secreted by human CD+34 cells,myeloblasts, erythroblasts and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner [J]. Blood, 2001,97(10) : 3075-3085.
